Cargando…

Elevated Levels of Endocannabinoids in Chronic Hepatitis C May Modulate Cellular Immune Response and Hepatic Stellate Cell Activation

The endocannabinoid (EC) system is implicated in many chronic liver diseases, including hepatitis C viral (HCV) infection. Cannabis consumption is associated with fibrosis progression in patients with chronic hepatitis C (CHC), however, the role of ECs in the development of CHC has never been explor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Patsenker, Eleonora, Sachse, Philip, Chicca, Andrea, Gachet, María Salomé, Schneider, Vreni, Mattsson, Johan, Lanz, Christian, Worni, Mathias, de Gottardi, Andrea, Semmo, Mariam, Hampe, Jochen, Schafmayer, Clemens, Brenneisen, Rudolf, Gertsch, Jürg, Stickel, Felix, Semmo, Nasser
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4425004/ https://www.ncbi.nlm.nih.gov/pubmed/25826533 http://dx.doi.org/10.3390/ijms16047057

Ejemplares similares

Hepatitis C Virus Infection Upregulates Plasma Phosphosphingolipids and Endocannabinoids and Downregulates Lysophosphoinositols
por: Beyoğlu, Diren, et al.
Publicado: (2023)

Elbasvir/Grazoprevir, an Alternative in Antiviral Hepatitis C Therapy in Patients under Amiodarone Treatment
por: Weiss, Lina, et al.
Publicado: (2018)

Juniperonic Acid Biosynthesis is Essential in Caenorhabditis elegans Lacking Δ6 Desaturase (fat-3) and Generates New ω-3 Endocannabinoids
por: Guha, Sujay, et al.
Publicado: (2020)

Targeted metabolomics shows plasticity in the evolution of signaling lipids and uncovers old and new endocannabinoids in the plant kingdom
por: Gachet, María Salomé, et al.
Publicado: (2017)

The Endocannabinoid Reuptake Inhibitor WOBE437 Is Orally Bioavailable and Exerts Indirect Polypharmacological Effects via Different Endocannabinoid Receptors
por: Reynoso-Moreno, Inés, et al.
Publicado: (2018)

4′-O-methylhonokiol increases levels of 2-arachidonoyl glycerol in mouse brain via selective inhibition of its COX-2-mediated oxygenation
por: Chicca, Andrea, et al.
Publicado: (2015)

Selective Endocannabinoid Reuptake Inhibitor WOBE437 Reduces Disease Progression in a Mouse Model of Multiple Sclerosis
por: Reynoso-Moreno, Ines, et al.
Publicado: (2021)

Association of endocannabinoids with pain in endometriosis
por: Andrieu, Thomas, et al.
Publicado: (2022)

Autoimmune hepatitis triggered by SARS-CoV-2 vaccination
por: Vuille-Lessard, Élise, et al.
Publicado: (2021)

Acute Hepatitis Induced by Lyprinol, the Lipid Extract of the Green-Lipped Mussel (Perna canaliculus), in a Patient with Polyarthrosis
por: Abdulazim, Amr, et al.
Publicado: (2012)

Robust Regression Analysis of GCMS Data Reveals Differential Rewiring of Metabolic Networks in Hepatitis B and C Patients
por: Simillion, Cedric, et al.
Publicado: (2017)

Belimumab treatment in autoimmune hepatitis and primary biliary cholangitis – a case series
por: Kolev, Mirjam, et al.
Publicado: (2023)

Pilot Sub-Study of the Effect of Hepatitis C Cure by Glecaprevir/Pibrentasvir on the Gut Microbiome of Patients with Chronic Hepatitis C Genotypes 1 to 6 in the Mythen Study
por: Yilmaz, Bahtiyar, et al.
Publicado: (2021)

Mycophenolate mofetil as second line treatment in autoimmune hepatitis – A retrospective single center analysis
por: Kolev, Mirjam, et al.
Publicado: (2022)

Molecular epidemiology of hepatitis B virus infection in Switzerland: a retrospective cohort study
por: Hirzel, Cédric, et al.
Publicado: (2015)

Adult form of Langerhans cell histiocytosis with pulmonary and hepatic involvement mimicking malignancy in a patient with chronic hepatitis C infection
por: Moullet, Barbara, et al.
Publicado: (2020)

Medicinal Cannabis: In Vitro Validation of Vaporizers for the Smoke-Free Inhalation of Cannabis
por: Lanz, Christian, et al.
Publicado: (2016)

Plasma Levels of K18 Fragments Do Not Correlate with Alcoholic Liver Fibrosis
por: Schlossberger, Viola, et al.
Publicado: (2019)

Prognostic Significance of Controlled Attenuation Parameter in Patients With Compensated Advanced Chronic Liver Disease
por: Margini, Cristina, et al.
Publicado: (2018)

Pepcan-12 (RVD-hemopressin) is a CB2 receptor positive allosteric modulator constitutively secreted by adrenals and in liver upon tissue damage
por: Petrucci, Vanessa, et al.
Publicado: (2017)

Hepatic Stellate Cells and Hepatocarcinogenesis
por: Barry, Anna E., et al.
Publicado: (2020)

Hepatic stellate cells: central modulators of hepatic carcinogenesis
por: Thompson, Alexandra I, et al.
Publicado: (2015)

Impact of geographic origin on access to therapy and therapy outcomes in the Swiss Hepatitis C Cohort Study
por: Brezzi, Matteo, et al.
Publicado: (2019)

Immortal hepatic stellate cell lines: useful tools to study hepatic stellate cell biology and function?
por: Herrmann, Jens, et al.
Publicado: (2007)

All-Cause Mortality and Causes of Death in the Swiss Hepatitis C Cohort Study (SCCS)
por: Roelens, Maroussia, et al.
Publicado: (2020)

Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis
por: Schon, Hans-Theo, et al.
Publicado: (2016)

PPAR Gamma and Hepatic Stellate Cells
por: Hazra, Saswati, et al.
Publicado: (2004)

Loss of hepatic Mboat7 leads to liver fibrosis
por: Thangapandi, Veera Raghavan, et al.
Publicado: (2021)

Osthole ameliorates hepatic fibrosis and inhibits hepatic stellate cell activation
por: Liu, Ya-Wei, et al.
Publicado: (2015)

Mechanical homeostasis imbalance in hepatic stellate cells activation and hepatic fibrosis
por: Zhao, Yuan-Quan, et al.
Publicado: (2023)

Insights into the impact of hepatitis B virus on hepatic stellate cell activation
por: You, Hongjuan, et al.
Publicado: (2023)

The Effects of Old Age on Hepatic Stellate Cells
por: Warren, Alessandra, et al.
Publicado: (2011)

Irisin Regulates the Functions of Hepatic Stellate Cells
por: Dong, Hanh Nguyen, et al.
Publicado: (2020)

Proteomic Changes of Activated Hepatic Stellate Cells
por: Schinagl, Maximilian, et al.
Publicado: (2021)

Hepatic Stellate Cell-Immune Interactions in NASH
por: Carter, James K., et al.
Publicado: (2022)

Methodologies for the Analysis of HCV-Specific CD4(+) T Cells
por: Lokhande, Megha U., et al.
Publicado: (2015)

Rational development and application of biomarkers in the field of autoimmunity: A conceptual framework guiding clinicians and researchers
por: Kolev, Mirjam, et al.
Publicado: (2022)

Expression of angiotensinogen during hepatic fibrogenesis and its effect on hepatic stellate cells
por: Lu, Ping, et al.
Publicado: (2011)

Bevacizumab Attenuates Hepatic Fibrosis in Rats by Inhibiting Activation of Hepatic Stellate Cells
por: Huang, Yangqing, et al.
Publicado: (2013)

The potential of mecciRNA in hepatic stellate cell to regulate progression of nonalcoholic hepatitis
por: Liu, Boqiang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_d70fs2t5sdaffe34m1d0etd5h2